Literature DB >> 22092640

Equine degenerative myeloencephalopathy in Lusitano horses.

C J Finno1, R J Higgins, M Aleman, R Ofri, S R Hollingsworth, D L Bannasch, C M Reilly, J E Madigan.   

Abstract

BACKGROUND: Equine degenerative myeloencephalopathy (EDM) is a neurodegenerative disorder that has been previously associated with low vitamin E concentrations.
OBJECTIVE: To describe the clinical, electrophysiologic, and pathologic features of EDM in a group of related Lusitano horses. ANIMALS: Fifteen Lusitano horses. PROCEDURES: Neurologic examinations were conducted, and serum vitamin E concentrations were measured. Three neurologically abnormal horses were further evaluated by ophthalmologic examination, electroretinography, electroencephalography, muscle and nerve biopsies, and post-mortem examination.
RESULTS: Six horses appeared neurologically normal, 6 were neurologically abnormal, and 3 had equivocal gait abnormalities. Abnormal horses demonstrated ataxia and paresis. An inconsistent menace response was noted in 4 neurologically abnormal horses and in 1 horse with equivocal findings. All horses had low serum vitamin E concentrations (<1.5 ppm). Ophthalmologic examinations, electroretinograms, electroencephalograms, and muscle and peripheral nerve biopsies were unremarkable in 3 neurologically abnormal horses. At necropsy, major neuropathological findings in these horses were bilaterally symmetric, severe, neuro axonal degeneration in the gracilis, cuneatus medialis, cuneatus lateralis, and thoracicus nuclei and bilaterally symmetric axonal loss and demyelination mainly in the dorsolateral and ventromedial tracts of the spinal cord. A diagnosis of EDM was made based on these findings. Pedigree analysis identified 2 sires among the affected horses. CONCLUSIONS AND CLINICAL RELEVANCE: Equine degenerative myeloencephalopathy is a neurodegenerative disorder that causes ataxia and, in severe cases, paresis, in young Lusitano horses. The disease appears to have a genetic basis, and although vitamin E deficiency is a common finding, low serum vitamin E concentrations also may occur in apparently unaffected related individuals.
Copyright © 2011 by the American College of Veterinary Internal Medicine.

Entities:  

Mesh:

Year:  2011        PMID: 22092640     DOI: 10.1111/j.1939-1676.2011.00817.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  10 in total

1.  Pigment retinopathy in warmblood horses with equine degenerative myeloencephalopathy and equine motor neuron disease.

Authors:  Carrie J Finno; Heather J Kaese; Andrew D Miller; Giuliana Gianino; Thomas Divers; Stephanie J Valberg
Journal:  Vet Ophthalmol       Date:  2016-08-05       Impact factor: 1.644

2.  Neurologic conditions in the sport horse.

Authors:  Daniela Bedenice; Amy L Johnson
Journal:  Anim Front       Date:  2022-06-14

3.  Evidence of the Primary Afferent Tracts Undergoing Neurodegeneration in Horses With Equine Degenerative Myeloencephalopathy Based on Calretinin Immunohistochemical Localization.

Authors:  C J Finno; S J Valberg; J Shivers; E D'Almeida; A G Armién
Journal:  Vet Pathol       Date:  2015-08-07       Impact factor: 2.221

4.  Pedigree analysis and exclusion of alpha-tocopherol transfer protein (TTPA) as a candidate gene for neuroaxonal dystrophy in the American Quarter Horse.

Authors:  C J Finno; T Famula; M Aleman; R J Higgins; J E Madigan; D L Bannasch
Journal:  J Vet Intern Med       Date:  2012-11-27       Impact factor: 3.333

5.  Current dorsal myelographic column and dural diameter reduction rules do not apply at the cervicothoracic junction in horses.

Authors:  Krista Estell; Mathieu Spriet; Kathryn L Phillips; Monica Aleman; Carrie J Finno
Journal:  Vet Radiol Ultrasound       Date:  2018-07-11       Impact factor: 1.363

Review 6.  Equine degenerative myeloencephalopathy: prevalence, impact, and management.

Authors:  Erin N Burns; Carrie J Finno
Journal:  Vet Med (Auckl)       Date:  2018-09-07

7.  Genome-Wide Association Study and Subsequent Exclusion of ATCAY as a Candidate Gene Involved in Equine Neuroaxonal Dystrophy Using Two Animal Models.

Authors:  Erin N Hales; Christina Esparza; Sichong Peng; Anna R Dahlgren; Janel M Peterson; Andrew D Miller; Carrie J Finno
Journal:  Genes (Basel)       Date:  2020-01-10       Impact factor: 4.096

8.  Effects of feeding two RRR-α-tocopherol formulations on serum, cerebrospinal fluid and muscle α-tocopherol concentrations in horses with subclinical vitamin E deficiency.

Authors:  J C Brown; S J Valberg; M Hogg; C J Finno
Journal:  Equine Vet J       Date:  2017-05-25       Impact factor: 2.888

9.  Safety and efficacy of subcutaneous alpha-tocopherol in healthy adult horses.

Authors:  C G Donnelly; E Burns; C A Easton-Jones; S Katzman; R Stuart; S E Cook; C J Finno
Journal:  Equine Vet Educ       Date:  2020-06-04       Impact factor: 1.063

10.  Previously Identified Genetic Variants in ADGRL3 Are not Associated with Risk for Equine Degenerative Myeloencephalopathy across Breeds.

Authors:  Sabin A Marquardt; Callie V Wilcox; Erin N Burns; Janel A Peterson; Carrie J Finno
Journal:  Genes (Basel)       Date:  2019-09-05       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.